Comparing knowledge, attitude, practice and stigma associated with SARS- COV-2 Infection among Healthcare students of Bangalore city: A cross sectional study

Published

2021-12-31

DOI:

https://doi.org/10.47203/IJCH.2021.v33i04.020

Keywords:

SARS- CoV-2, Knowledge, Stigma, Infection, Healthcare Students

Dimensions Badge

Issue

Section

Short Article

Authors

Abstract

Background: In 2020, a new global pandemic has emerged, caused by a new strain of Corona virus called SARS-CoV-2. A poor understanding of the disease among healthcare students may implicate in delayed treatment and rapid spread of infection and development of complications.  Objectives: 1) To estimate the knowledge, attitude, practice and stigma associated with SARS- CoV-2 infection among healthcare students. 2) To estimate the association between socio-demographic determinants with knowledge, attitude, practice and stigma of SARS- CoV-2 infection among healthcare students. Methods: A web-based cross-sectional study was undertaken among 493 healthcare i.e., medical, nursing and allied sciences students, during 1st May to 20th May 2020, using a pre-designed and semi-structured questionnaire. Data was analyzed using Chi square test, t-test, one way Anova and Bonferroni test was used for assessing the association among the study variables. Results: The study revealed that, there were about 225(45.64%) medical, 165(33.46%) nursing and 103(20.89%) allied sciences students. Majority were females 349(70.79%), majority were Hindus 333(67.54%). Mean knowledge score of medical, nursing and allied sciences students were 15.66 (2.518), 14.16 (2.92) and 14.46 (3.11) respectively. Practice score was good among nursing than allied sciences students at ‘p’ (0.003). Conclusion: Even though the overall knowledge was less in our study participants, majority of them had followed good practices for preventing SARS- CoV-2 infection.

How to Cite

1.
N K B, N S, Kurre B. Comparing knowledge, attitude, practice and stigma associated with SARS- COV-2 Infection among Healthcare students of Bangalore city: A cross sectional study. Indian J Community Health [Internet]. 2021 Dec. 31 [cited 2022 Aug. 19];33(4):658-62. Available from: https://iapsmupuk.org/journal/index.php/IJCH/article/view/2219

Downloads

Download data is not yet available.

References

World Health Organization. Global tuberculosis report 2020. Geneva: WHO; 2020. p34.

Basil A, Ahmad N, Khan AH, Javaid A, Syed Sulaiman SA, Afridi AK et al. Predictors of two months and the conversion in the multi drug resistant tuberculosis: Findings from a retrospective cohort study. PLoS One. 2014; 9(4):e93206.

Jain K, Desai M, Solanki R, Dikshit RK. Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis. J PharmacolPharmacother. 2014; 5(2):145-9.

World Health Organization. Global tuberculosis report: Geneva: WHO; 2017:17.

Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. India Tb Report 2020. New Delhi, India. 2020:292.

Guideline for PMDT in India 2017?: Central TB Division. Available at: https://tbcindia.gov.in/index1.php?lang=1& level=2&sublinkid =4780&li =3306. Accessed on 25/12/2021.

World Health Organization. Global tuberculosis report 2016. Geneva: WHO; 2016.

World Health Organization. Global tuberculosis report: Geneva: WHO; 2019:3

Gupta N, Jorwal P. Treatment outcomes associated with multidrug-resistant tuberculosis. J Glob Infect Dis.2018; 10(3):125–8.

Agarwalla, Bhattacharya S, Dey A, Kar S, Chaudhuri AD. Study of outcome of management of MDR-TB cases under programmatic condition in India. J Dr NTR Univ Heal Sci. 2019;8(1):1.

Janmeja AK, Aggarwal D, Dhillon R. Analysis of treatment outcome in multi-drug resistant tuberculosis patients treated under programmatic conditions. Int J Res Med Sci. 2017; 5(6):2401.

Kibret KT, Moges Y, Memiah P, Biadgilign S. Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies. Infect Dis Poverty. 2017; 6(1):7.

Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic. Available at: https://www.who.int/news/item/14-10-2021-tuberculosis-deaths-rise-for-the-first-time-in-more-than-a-decade-due-to-the-covid-19-pandemic. Accessed on 25/12/2021.